Streetbeat News

Regulatory

SPY

The S&P Global US Manufacturing PMI for October was reported at 50, beating the estimate of 49.5 and the prior figure of 49.8.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:46 pm

SPY

The S&P Global Composite PMI for October has increased to 51.0 from 50.2 in the previous month.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:45 pm

MARA

RIOT

Crypto mining stocks Marathon Digital Holdings Inc (NASDAQ:MARA) and Riot Platforms Inc (NASDAQ:RIOT) are trading higher as Bitcoin's price continues to rise due to optimism surrounding a potential spot ETF. BlackRock and other financial firms have made changes to their submissions for spot Bitcoin ETFs. JPMorgan anticipates the SEC will approve a spot ETF within the next few months.

Portfolio Pulse from Adam Eckert

October 24, 2023 | 1:40 pm

BTCUSD

ETHUSD

The article discusses the factors that investors consider when pricing digital assets like Bitcoin (BTC) and Ethereum (ETH). These factors include supply and demand, utility, risk, and speculation. The article also mentions Benzinga's upcoming conference on digital assets, which will cover topics like the future of Bitcoin and Ethereum, decentralized finance (DeFi), non-fungible tokens (NFTs), and the regulatory landscape for digital assets.

Portfolio Pulse from Murtuza Merchant

October 24, 2023 | 1:32 pm

ANVS

Annovis Bio, Inc. (NYSE:ANVS) presented promising results from its drug development for neurodegenerative diseases at the Clinical Trials on Alzheimer's Disease (CTAD) 2023 conference. The drug, buntanetap, inhibits the production of neurotoxic proteins responsible for Alzheimer's and Parkinson's diseases. The findings have been replicated in all human phase I and II trials to date, demonstrating decreased levels of toxic proteins, improved axonal transport, reduced inflammation, and neuroprotection. The company is currently in phase III trials and discussing the path forward with the FDA.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:15 pm

NVDA

Nvidia Corp has announced that the Interim Final Rule will affect the shipments of its A100, A800, H100, H800, and L40s products.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:04 pm

NVDA

SPY

Nvidia has stated that it does not expect the accelerated timing of licensing requirements to have a significant impact on its near-term financial results. This comes after the US government informed the company about the implementation of additional export controls on some semiconductors.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:03 pm

JAZZ

TLRY

The medical marijuana program in Luxembourg is facing supply shortages due to a change in cannabis flower supplier from Tilray Brands Inc. to Schroll Medical. In Ireland, Jazz Pharma's Sativex is now available for reimbursement for treating MS-caused spasticity in adults. In the UK, families are struggling to obtain cannabis oil for medical purposes, despite its legalization for prescription by specialist doctors in 2018.

Portfolio Pulse from Nina Zdinjak

October 24, 2023 | 12:57 pm

EGRX

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) has been granted a patent for its pemetrexed formulations, including the FDA-approved commercial formulation of PEMFEXY®. The patent, which will expire in 2036, has been submitted for listing in the U.S. Food and Drug Administration's Orange Book. This is the second patent to be listed in the Orange Book for PEMFEXY. The company has not received any notice of a Paragraph IV certification for an application referencing PEMFEXY.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:41 pm

SPY

The Philadelphia Fed Wage and Benefit Cost Index has decreased to 34.2 in October from 40.3 in September.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:39 pm